Key Highlights: Implications: Alkem’s launch of NeuCeno (cenobamate) introduces India’s first cenobamate-based anti‑seizure medication for adults with partial‑onset seizures, adding a high...
Key Highlights: Implications: The launch positions Eisai to capture first-mover advantage in India’s underpenetrated dementia market, where prevalence is already large and expected t...
Key Highlights Implications: Lormalzi gives Lilly an early foothold in India’s tiny but fast‑growing market for disease‑modifying Alzheimer’s drugs, while it test...
Key Highlights: Implications: Rubicon is using the Arinna deal to buy its way into India’s fast‑growing CNS and neuro‑psychiatry market with an immediately revenue‑accretive, chr...
Key Highlights: Implications: Rusan’s new APOSAN 3 ml multi‑dose pen broadens at‑home rescue options for Indian Parkinson’s patients by adding a dial‑a‑dose, cartridge‑based apom...
Key Highlights: Implications: The dispersible format gives Akums a clear differentiation edge in the acute migraine space, directly addressing nausea and swallowing difficulties that often...
